Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.
You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.
After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.
“AIDS is kind of like life, just speeded up. ” JavonP. ,heroinaddictwithAIDS, Bronx,NewYork, 1988 “Now I’m not so much scared of dying as scared of living. ” Mike D. , heroin addict with AIDS, New Haven, Connecticut, 1998 Within little more than a decade, AIDS has been tranformed from an untreatable, rapidly fatal illness, into a manageable, chronic disease. Most of this tranformation has occurred in the past five years, accelerated by the advent of protease inhibitors and the proven benefits of combination antiretroviral therapy and prophylaxis against opportunistic infections. For people living with HIV/AIDS, these developments have offered unprecedented hope, and also new challenges. As reflected in the quotes above, some of the anxieties and anticipation of premature dying have been replaced by the uncertainties involved in living with a long-term, unpredictable illness. The role of caregivers for people with HIV/AIDS has also changed radically over this time. Earlier in the epidemic, we learned to accompany patients through illness, to bear witness, to advocate, to address issues of death, dying, and - reavement. The arrival of more effective therapy has brought with it new capabi- ties, but also new complexities, raising difficult problems concerning access to care, adherence, and toxicity.
Content Level »Research
Keywords »AIDS - HIV - HIV/AIDS - Public Health - prevention
1. Combination Antiretroviral Chemotherapy: Shifting Paradigms and Evolving Praxis; K.H. Mayer. 2. Pharmacokinetics of Protease Inhibitors and Drug Interactions with Psychoactive Drugs; S.K. Chuck, et al. 3. Treatment Adherence to HIV Medications: The Achilles Heel of the New Therapeutics; J.G. Rabkin, M. Chesney. 4. Combination Antiretroviral Therapies for HIV: Some Economic Considerations; S.D. Pinkerton, D.R. Holtgrave. 5. Ethical Issues in the Use of New Treatment for HIV; E. Heitman, M.W. Ross. 6. Mental Health Implications of new HIV Treatments; S.C. Kalichman, B. Ramachandran. 7. Practical Prevention Issues; D.G. Ostrow. 8. Postexposure Prophylaxis: A Community Member's Perspectives; M. Shriver. 9. Behavioral Research Needs and Challenges of Nnew Treatments: AIDS as a Chronic Illness; W. Pequegnat, E. Stover. Glossary. Index.